Cytokinetics
Kat Korhonen currently serves as a Scientist I and Lab Manager at Cytokinetics, focusing on developing animal models for testing drug therapies aimed at muscular degenerative diseases. This role includes model validation and post-data processing, along with extensive experience in pharmacodynamic studies involving various techniques such as echocardiography and transcriptome analysis. Prior experience at the University of Connecticut included positions as a Graduate Research Student, where research centered on Streptococcus pneumonia infection in Sickle Cell Disease and the role of host protein Cyclophilin A in poxvirus replication, contributing to potential antiviral drug target insights. Kat Korhonen holds a Master’s Degree in Pathobiology and a Bachelor’s Degree in Molecular and Cell Biology with a minor in Physiology from the University of Connecticut.
This person is not in any teams
This person is not in any offices
Cytokinetics
16 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.